Rocket Lab Q2 Loss Narrows

Rocket Lab Corp (RKLB) reported Q2 results with revenue up 62% year over year to $234.1 million. Net loss narrowed to $49.3 million, or $0.08 per share, from $66.4 million, or $0.13 per share. For Q3, the company forecast revenue of $250 million to $265 million and gross margin of 29% to 31%.

Original reporting
Published Aug 10, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 11:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RKLB
Bullish
medium confidence
Mentioned
$RKLB
Relevance
7/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

Loss narrowing and accelerating revenue growth can improve investor confidence, while the guided gross margin range sets expectations for profitability trajectory.

02

Market read

Traders can update models using the reported Q2 figures and the explicit Q3 revenue and gross margin ranges.

03

What to watch

The article does not break out segment margins or backlog, so traders may discount the quality of growth and focus on execution risk into Q3.

Relevance 7/10Novelty 6/10Timing: reported Monday after-hours/late day

Background

Rocket Lab is a space launch and space systems provider; this update covers Q2 results and forward guidance for Q3.

Company-level read

Ticker impact

$RKLBBullishMedium confidence
Context

Rocket Lab reported Q2 revenue up 62% YoY to $234.1M and narrowed net loss to $49.3M, plus issued Q3 revenue and gross margin guidance.

Expected impact

Moderate positive bias for the next few sessions as traders reprice the guidance range and margin outlook.

Evidence & confidence

The article provides concrete Q2 results and explicit Q3 guidance (revenue $250M-$265M, gross margin 29%-31%), which are actionable inputs for valuation and positioning.

Market effects

Reinforces demand momentum in launch and space systems, which can marginally lift sentiment across space/launch peers.

Limited, primarily affects US-listed space sector sentiment.

Low to moderate, as it is company-specific guidance rather than a macro or policy driver.

Counterpoint

Revenue growth may not translate into sustained profitability if gross margin fails to hold within the guided 29%-31% band.

Key entities

  • Rocket Lab Corporation

    Reported Q2 revenue growth, narrowed net loss, and provided Q3 revenue and gross margin guidance.

Related articles

$RKLBMedAI 8/10

Rocket Lab (RKLB) Q2 2026: Record Revenue, Acquisitions Dent EPS

Rocket Lab reported Q2 2026 revenue of $234.07M, above the $230.94M consensus, up 62% year over year. Product revenue rose to $181.35M. GAAP EPS was -$0.08 versus -$0.0767, with the miss linked to $8.6M acquisition-related transaction costs. Backlog grew to $2.36B and Q3 revenue guidance was $250M-$265M.

$RKLBMedAI 8/10

Rocket Lab Just Delivered Record Results. So Why Is the Stock Sinking?

Rocket Lab (RKLB) reported Q2 record revenue of $234 million, up 62% year over year, and a net loss of $49 million, or $0.08 per share. Revenue beat consensus ($231.6 million) but loss was wider than expected ($0.03). Backlog rose 137% to $2.36 billion, with $1B+ new contracts and $397 million U.S. Space Force Flatellites deal. Q3 revenue guidance is $250-$265 million.

$RKLBHighAI 8/10

Live: Will Rocket Lab Soar Back to All-Time Highs After Q2 Earnings Tonight?

Rocket Lab (NASDAQ:RKLB) is set to report Q2 FY2026 earnings on Aug. 10. Management guided Q2 revenue to $225M-$240M, about 60% YoY growth, supported by a $2.2B backlog and recent defense contract wins including a $266M Space Force suborbital contract and $397M Flatellites award. The article highlights Neutron timing and margin deceleration as key investor focus.

$RKLBMed

Window for 2026 launch debut of Rocket Lab’s Neutron rocket ‘is narrowing’ as development continues – Spaceflight Now

Rocket Lab said in an SEC filing that Neutron’s end-of-year launch window is narrowing, with Stage 1 tank production aligned to a Q4 2026 delivery to the launch pad. Exact timing depends on first-stage qualification and other tests. The company also cited a $397 million US Space Force SB-AMTI contract and a dedicated Kepler mission no earlier than 2028.